Planning Strategies’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Planning Strategies's BMY Position: Q3 2026 in Review
Planning Strategies increased its Bristol-Myers Squibb (BMY) stake by 1.7% in Q3 2026, buying an estimated $1.45K and bringing the position to 1,384 shares worth $86.4K. The position accounts for 0.05% of the portfolio, ranked #119.
Planning Strategies first reported a position in BMY in Q2 2026 and has held it in 2 quarters since. 2,568 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Planning Strategies held 1,384 shares of Bristol-Myers Squibb worth $86.4K as of Q3 2026.
- Planning Strategies bought 23 Bristol-Myers Squibb shares in Q3 2026, an estimated $1.45K.
- Bristol-Myers Squibb made up 0.05% of Planning Strategies's portfolio in Q3 2026, its #119 holding.
- Planning Strategies first reported a position in Bristol-Myers Squibb in Q2 2026 and has held it in 2 quarters since.
- 2,568 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Planning Strategies's 13F filing for Q3 2026, filed 2 Oct 2026.